Probiotics: Concepts

1/22/2014 10:43:17 AM
By J.J. Mallo, Norel S.A Animals and bacteria present a mutualist relation: Animals need a well balanced bacterial population in the gastrointestinal tract to maintain a healthy status, avoid sicknesses and digest nutrients that would not be available for them without the bacteria, and the bacteria need the animal to provide an appropriate environment to develop their population and a constant supply of nutrients. Veterinarians and nutritionists have always dealt with the gut microbiome and its variations, normally with the use of antibiotics at subtherapeutic dosage (also known as antibiotic growth promoters). The appearance of new trends in EU and in the rest of the world to produce animals without using antibiotic growth promoters (to avoid cross resistances) has led to the finding of solutions, as probiotics, that help the nutritionist to provide a diet that not only covers the nutritional needs, but also the requirements to maintain a healthy status and reduce the possibilities of suffering diseases. The use of probiotics in animal nutrition is common in the EU and is growing in the rest of the world (also combined with antibiotics, with synergistic effects), this document describes the ideal probiotic and shows examples of what can be expected when a probiotic is used in the feed.

Introduction:

The bacterial population that resides in the animals´ gastrointestinal tract changes with time and with external conditions. The gut microbiota of the birds is affected by  the icrobiota  present  in  the  environment  at  hatch,  and  the  nutrient composition of their diet (Torok, 2011). After that, any minor change in the food (higher inclusion of certain raw material, different origin of ingredients), the use of medicines, and/or  changes in temperature  or light schemes  may produce  disbalance in the gastrointestinal tract microflora, with fatal consequences for an disbalance in the gastrointestinal tract microflora, with fatal consequences for an in-farm animal (Torok, 2011). There are many different bacterial species in a healthy intestine, 30 different genus and more than 600 species (Smith, 1965) and they provide certain benefits to the host, namely, nutrient digestion, energy production (Mallo, 2012)ǥ However some of these may become pathogenic given certain circumstances, or an imbalance in the populations may bring a sickness. 

The gut microbiota is a complex and dense system (populations may vary between 103 to 1011 CFU/g of intestinal content, depending on the organ), that has a significant impact on the host’s health, growth and immune status (Smith, 1965). It is an important barrier that interferes with the pathogens, formed by beneficial micro-organisms   that   suppresses  the   pathogenic   bacteria   populations (by competitive exclusion, competing for the attachement sites, or by direct reduction of population by the production of natural antibiotics) and induces immune response in different mucous membranes.

 

The concept “probiotic” has its origin in human nutrition. The term probiotic is derived from two words: the latin word “prode”, that means “for”, and from the Greek, “βιο”, that means “life”. There are many definitions for the term “probiotic”. Within the existing definitions, one widely used is the one of Fuller (1989), who defined them as "A live microbial feed supplement which beneficially affects the host animal by improving its intestinal microbial balance". This benefit is normally observed as an improvement of growth performance, feed conversion and even mortality (Mallo, 2010).

 

Every probiotic, or direct fed microbial (DFM) mechanistic is different from the rest, but all of them have many points in common:

-     They are viable industrially

-     They are active in the gastro-intestinal tract (GIT)

 

-     They produce benefits to the host

Viability as probiotic:

The first check-point in a probiotic is the bacterial composition. A probiotic can present a simple composition (one or two bacteria), when it supplements the feed with a very high concentration of a limited number of bacteria, or multi-strained, when it iscomposed of more than two species of bacteria. The activity of a single strain probiotic (or that of a probiotic composed by 2 bacterial species) is normally well defined and can be demonstrated by in-vitro and in-vivo essays, whilst the multi-strain probiotic activities are more difficult to explain.

The  bacteria  used  in  the  probiotics  can  be  autochthonous  to  the  animal´s gastrointestinal tract, or allochthonous to  it.

 

 The   autochthonous   bacteria   are   normally   lactic   flora,   belonging   to  the Lactobacillus,
 
Bifidobacterium  or  Enterococcus  species, and  the allochthonous bacteria normally belong to the Bacillus or Clostridium species (see table 1 for examples).

 Table 1.- Examples of bacteria used as probiotics depending on their 
                                           sporogenous capacity

Non-Sporogenous

Sporogenous

L. acidophilus

B. subtilis

L. brevis

B. amyloliquefaciens

L. Lactis

B. licheniformis

L. reuteri

B. cereus

L. plantarum

C. butyricum

L. farciminis

 

L. bulgaricus

 

E. faecium

 

P. acidilactici

 

B. bifidum

 

B. termophilum

 

The lactic flora is adapted very well and rapidly to the gastrointestinal tract (Table 2) becoming the predominant flora and avoiding pathogenic bacteria infections by competitive exclusion (Bielke, 2003; Taheri, 2009). However, these bacteria arenormally  gram-  bacteria  or  non-sporogenous  gram+  bacteria.  This  presentsserious difficulties at handling: short shelf life (probiotics of this class are freeze dried cell cultures that need to be stored below 8ºC), low survival in pelleting process, incompatibility with acids, antibiotics and anticoccidial drugsǥ.

 

Table 2.- Time required to duplicate populations (in-vitro assay; Díaz, 2007)

Bacteria

Time (minutes)

L. acidophilus

64

L. bulgaricus

40

S. termophilus

46

E. faecium

19

E. coli

20

S. cerevisiae

200

B. subtilis

60

 

Allochthonous bacteria, however, are normally selected to endure normal storage conditions, survive the pelleting process and also to be compatible with acidifiers, antibiotics and anticoccidial drugs. These bacteria (Bacillus and Clostridium) are normally sporogenous  bacteria,  they  form  spores  when  the  environment  is adverse, and can stay latent in the spore, resistant form, until the environment is adequate for the vegetative bacteria. Industrially, sporulation is induced at the end of the probiotic production, achieving a very stable product that will work only once inside the animal. Many of these allochtonous bacteria can be found in the GIT of healthy animals that have not received any probiotic, demonstrating how the environment influences the microbial population.

In both cases, probiotics should be non-pathogenic, resist gastric pH and bile, resit processing, stable in storage, be able to adhere to gut epithelium, persist in the gastrointestinal tract, produce inhibitory compounds, modulate immune response and alter other microbial activities in the gut (Siragusa, 2012).

The selected bacteria are grown in large-scale industrial fermentors, then, a concentrate of bacteria is made by centrifugation to collect the concentrated bacterial powder afterwards by spray-drying, freeze drying or filtering.

(Cont in next article)